This paper examines the impact of judicialisation on the right to cross-border healthcare in Denmark and Spain, i.e., the national impact of legal integration as spurred by the Court of Justice of the European Union (CJEU). We expect the national impact of judicialisation to be conditioned by the ex-post judicial, administrative and political responses, particularly the national courts' activation of EU law. By using new data, a compilation of national court cases, quasi-judicial proceedings and research interviews with key respondents, we examine the process of judicialisation in the two member states. The findings demonstrate that the national courts hardly played a role in Denmark and that although the courts were more active in Spain, the rulings remained largely unobserved by the political and administrative elite and the courts were thus unable to push for change. The administrative and political responses were found to be quite similar in the two member states, adapting to EU-induced changes in a protectionist and defensive manner. We conclude that the two universalistic healthcare models have so far proved resistant to judicialisation and that the discrepancy between what emerges de jure at the supranational level and the de facto rights produced at the national level is still a wide one.
Introduction
It is increasingly held that European politics has become judicialised, a process through which courts are becoming more involved in settling political disputes and come to propel political change. Although identified as a global trend, the judicialisation of politics should be particularly strong in the European Union (Kelemen 2013, 295) . In European integration, judicialisation may occur at both the supranational and national levels.
It involves both the Court of Justice of the European Union (CJEU), which produces change by means of legal integration, and the national courts, as decentral enforcers of European law. The CJEU is famous for its ability to take European integration forward, and its judicial interpretations -if they are fully taken on boardwould undoubtedly transform a large set of national policies and politics. However, such court-driven change could hardly occur uncontested. Central questions of theoretical and empirical importance remain open. To what extent does judicialisation produce national impact? How may ex-post judicial, administrative and political responses and interactions condition the impact of judicialisation, i.e., reactions after a supranational judicial decision has been rendered (Ginsburg 2014, 490-494) ?
In this paper, we examine the impact of legal integration on cross border healthcare in Denmark and Spain.
Until the late 1990s, the right to receive healthcare services in another member state was limited by a Treaty, which set out that the delivery and organisation of healthcare was the responsibility of the member states.
Additionally, regulation 1408/71 (now regulation 883/2004) on the coordination of social security for migrant workers stated that planned healthcare treatment could only be sought in other member states and reimbursed in the home state if it had been authorised beforehand by the relevant national authority. The division of competences between the EU and the national level was thus fairly clearly set out.
The high degree of national control has subsequently been challenged by two sequences of EU-invoked change. First, the established regulatory status quo was challenged by a line of CJEU case law that specified that healthcare was not exempted from single market principles.
1 Second, as a response to this line of CJEU jurisprudence, a Patient Rights Directive (PRD) has been adopted, which has subsequently been transposed in the member states. 2 The PRD is the collective political response to previous legal integration. In the course of legal integration, the CJEU has established that healthcare is a service within the meaning of the treaty. In its line of case-law, it has clarified that internal market principles also apply to hospital care, but it draws a distinction between hospital care and non-hospital care. Hospital care may, under certain conditions, justify prior authorisation. The Court, however, found that for non-hospital care, prior authorisation was an unjustified barrier to the free circulation of services. Jurisprudence had established a situation of legal uncertainty, and member states requested that the European Commission come up with a proposal to clarify matters. It took the Commission ten years to present a proposal that separately dealt with cross border Directive became a reality. The output of political negotiations had, however, modified what the Court had initiated (Martinsen 2015) . Considerably more national control was put in place during the negotiations. As stated in article 8 of the PRD, prior authorisation can be permitted for hospital care but also for highly specialised and cost-intensive care, and member states can themselves define what is classified as highly specialised and cost-intensive care, provided that such a classification is objective, proportionate and transparent. The European Commission was far from satisfied with the final result and found that it constituted a very restrictive interpretation of the case-law of the Court (COM (2010) 503, 7). However, as a response to political negotiations, the Court itself has become more cautious in its interpretation, taking a more 'tempered approach' (Hatzopoulos and Hervey 2013) . It now acknowledges that prior authorisation is also justifiable for highly specialised and costly healthcare 3 , thus allowing more national control for access to healthcare in another member state.
This paper first sets out the theoretical framework for examining the judicialisation of politics, followed by an empirical analysis of judicialisation and transposition in Denmark and Spain. The analysis draws on a new data set where we compiled national court cases and quasi-judicial proceedings that had based their decisions on the relevant CJEU jurisprudence. Furthermore, research interviews were held with key respondents in the two member states, including civil servants in charge of the transposition from the relevant ministries and regional authorities, representatives from patient organisations, boards for patient complaints, and representatives from the involved healthcare agencies, among others. A total of 22 semistructured interviews were conducted for the present study from August 2012 to October 2014.
A Judicialisation of Politics -From Legal Integration to National Change
In general, judicialisation marks a process where court rulings impact both politics and policy-making. The term has a dynamic connotation that suggests a broadened judicial impact at the expense of the parliament, the government and the executive (Rothmayr 2001, 77) . Judicialisation is noted as a global trend, but one that reaches 'its apotheosis in the European Union' (Kelemen 2013, 295) .
Whereas scholars of European integration generally agree on the Court as an important actor for European integration, they tend to disagree on what the broader impact of legal integration is, particularly when it runs counter to the political preferences of the governing majority. One group of scholars sees the political power of the Court as considerable indeed, with fundamental implications for politics (Kelemen 2013; Alter 2009; Stone Sweet 2000) . According to this view, politics is inexorably placed in the 'shadow' of constitutional review (Stone Sweet 2000, 202) . Parliamentary sovereignty, understood as majoritarian rule, has lost 'its grip' and has been 'steadily undermined' by the counter-ideology of modern constitutionalism (Stone Sweet 2000, 196) . The relationship between law and politics is one where judicial activity conditions politics, rather than the other way around.
"… Governments and parliaments have developed new practices designed to accommodate the constitutional law, as it is progressively elaborated by the court. Judicialisation provokes the emergence and institutionalisation of a new kind of legislative politics" (Stone Sweet 2000, 202-203) .
In this view, a 'judicialisation of politics' has gained traction in the European Union (Stone Sweet 2010, 7) .
Kelemen terms this highly judicialised mode of governance as Eurolegalism (Kelemen 2011 'routinely take decisions that they would not have taken in the absence of review, and governing majorities anticipate likely decisions of the court and constrain their behavior accordingly' (Stone Sweet 2000, 202) .
Other scholars note that although judicialisation is a growing trend, the impact of the judiciary on public policy outcomes depends on the subsequent political reactions (Hirschl 2008) . The political sphere needs to support judicial interventions for these to generate policy reforms. If litigation introduces a unwelcome development to the political elites, the political elites have many ways to 'quell unfavorable judgments' (Hirschl 2009b, 827; Fisher 1988, 200 ff.) Courts and their jurisprudence cannot be understood in isolation but are instead integral parts of the larger political and societal setting (Hirschl 2008, 97; Börzel 2006 ).
According to Hirschl, bureaucratic disregard or reluctant implementation of unwelcome jurisprudence constitutes a 'lethal' political response to judicialisation (Hirschl 2008, 110; see also Rosenberg 2008; Garrett, Kelemen, and Schulz 1998) . At the level of the European Union, scholars have disputed the extent to which legal integration spurs more general change in the EU member states and have criticised the assumption that CJEU "rulings are automatic catalysts for policy change and that innovative legal interpretation prompts wideranging reforms" (Conant 2002, 15) . Courts have neither purse nor sword and rely on third-party enforcement for their decisions to have more general impact (Conant 2002, 202; Greer and De Almagro Iniesta 2014, 363) . For CJEU decisions to have a national impact, they depend on domestic judicial, administrative and political institutions, which are unlikely to adapt without dispute to supranational judicialisation that contradicts national, political and legal cultures (Kagan 2008, 25; Börzel 2006 ).
The CJEU rulings on cross border healthcare constitutes our case for examining the extent to which supranational judicialisation produce concrete change at the national level. Cross border healthcare is likely to be a strong case for judicialisation because the CJEU, for many years, had extended the right de jure and because a large set of actors obviously have an interest in developing these rights; patients, patient organisations and providers, particularly private providers. At the same time, it is a policy area of strong national institutions with their own organisational logics and legacies. Therefore, the strength of judicialisation as a driver of de facto change is at test here.
By de facto change, we understand the outcome of judicialisation; i.e., an extension of the right to healthcare treatments across borders, found in national court decisions, in changed administrative practices or in changes of national law as well as in de facto patient mobility. It is important to note that concerning the right to cross border healthcare, there are two sequences of change: the first sequence runs from approximately 1998-2011 and concerns the national impact of legal integration as stemming from the caselaw of the Court. The second sequence covers the subsequent years 2011-2015 and concerns the national impact of political integration in cases where the PRD is implemented in the member states. Here, we examine the transposition of PRD article 8, which specifically lays down when prior authorisation is justified in the light of EU law. The authorisation procedure constitutes the means of national control that is challenged by EU law.
National Courts and Mode of Democracy as Pivotal to Judicialisation
To examine the national impact of judicialisation within the healthcare area, we analyse national responses in two Beveridge tax-financed healthcare models with universal coverage: Denmark and Spain. These two healthcare systems face the same set of systemic challenges from an extended choice of healthcare treatment across borders. Both systems rely on a high degree of public control on the provision and consumption of healthcare. Healthcare has traditionally been tied to the region of residence, free choice has been limited and the general practitioner (GP) has been the gatekeeper of assessing specialised and hospital care. However, the two EU member states differ in their modes of democracy and judicial culture, which may matter for the national impact of judicialisation. Informed by previous studies, we expect national courts to be pivotal to the national impact of judicialisation because they may guide or instruct the implementing behaviour of national bureaucrats and politicians (Alter 2001; Golub 1996; Obermaier 2009 ). We expect the national courts' activation of EU law to be important for impact. The scholarly literature on law and politics has primarily focused on the role of the national judiciary when sending preliminary references to the CJEU, thereby propelling European integration while potentially challenging national legal hierarchies and politics.
Few studies have looked into how national courts carry out their role as decentral enforcers of EU law. On a more theoretical account, Tallberg points to decentral enforcement as a particular strength of the EU, making non-compliance a merely temporal phenomenon (Tallberg 2002, 610) . Studying the implementation of the CJEU case-law on cross border health-care in France, Germany and the UK, Obermaier found national court activism to be key to national political and administrative responses (Obermaier 2009 ). The national judiciary was capable of pushing national politics into compliance. Along these lines, we thus expect national courts to adjudicate their own cases in accordance with the CJEU jurisprudence and thereby force the legislators to act and comply. We however also note other scholars' reservations against regarding decentral enforcement strategies as the 'panacea' for compliance; these scholars have noted that litigants often lack the necessary resources and time to carry out legal proceedings and that national courts may not have the capacity to or be willing to act as the decentral enforcer of EU law (Slepcevic 2009; Davies 2012; Conant 2001; Börzel 2006) .
Furthermore, different forms of democracy around which the relationship between court, legislator and executive is institutionalised may condition the national courts' ability or willingness to activate EU law in the national arena.
Denmark belongs to the tradition of majoritarian democracy, where parliamentary supremacy has traditionally defined the relationship between the courts and the legislator. Parliamentary majorities represent the 'will of the people', and in principle, such majorities should not be subject to judicial review (Wind, Martinsen, and Rotger 2009; Dworkin 1996; Ginsburg 2003; Wind 2010) . A judicial review in which courts can strike down legislation adopted by the political majority is considered counter-majoritarian and an unacceptable limit on democracy. It has been argued that belonging to the tradition of majoritarian democracy has made Danish courts more reluctant in sending preliminary references to the CJEU in the attempt to avoid supranational judicial review (Wind 2010; Wind, Martinsen, and Rotger 2009) . Furthermore, Denmark has no social courts; instead, complaints for the violations of rights can be submitted to quasijudicial court bodies: the Social Appeals Board and since 2011 the National Agency for Patients' Rights and
Complaints. The Social Appeals Board has traditionally appeared reluctant to consider EU law in its cases for appeal (Martinsen 2005) . We expect to find the same reluctance in regard to judicial Europeanisation, thus making Danish courts less active decentral enforcers of CJEU case-law.
Our expectations differ with regards to Spain. Spain belongs to the tradition of constitutional democracy.
After the Spanish transition to democracy in 1978, a European model of constitutional democracy was adopted, where courts were to exercise centralised judicial review by referring cases to the Constitutional Court to protect constitutional rights. The constitution supported strong regionalism and an enforceable body of fundamental rights and liberties (Sweet 2002, 83) . Similarly, national judges who are entitled to challenge the constitutionality of the laws enacted by the parliament may feel less reluctant than their Danish counterparts to review the compatibility of national law with EU law. In Spain, the right to healthcare is constitutionally settled as article 43 of the constitution. Moreover, the Spanish judicial Council has institutionalised a network of national judges expert on EU law (RED-UE) that traces the latest developments in the field of European law, provides information on the most relevant jurisprudence of the CJEU to their peers and assists Spanish judges with the use of preliminary references (Mayoral et al., 2013) , thus helping national judges integrate the jurisprudence of the CJEU in their rulings. We therefore expect Spanish courts to be active enforcers of the CJEU case law.
Decentral Judicialisation in Denmark and Spain
To account for the decentral judicialisation of the right to cross border healthcare role, we gathered national rulings that quoted the relevant CJEU rulings between the Decker and Kohll rulings of 1998 until January Providing public healthcare in Denmark is a shared responsibility primarily between the state and the five regions (Martinsen and Vrangbaek 2008, 173) . These five Danish regions are the main planners and providers of healthcare, whereas the state influences the sector through the budget and the overall regulatory framework.
Planning is an integral part of the Danish healthcare system. The 'family doctor', i.e., the General Practitioner (GP), serves as an important gatekeeper for healthcare treatment and has been considered important for the quality of care, bridging patients' demands and system supply. The GP thus has a very important control function in the Danish system, referring patients to specialist treatment and hospital care. A patient, once referred by the GP, has an extended free choice of hospital care if s/he cannot be treated within two months in his/her own region. In that case, the patient can choose healthcare at a public hospital in another region or at a private or foreign healthcare provider with which the Danish regions established an agreement beforehand. 
Judicialisation of Danish Healthcare: Defensive Absorption
The Danish implementation of the CJEU case law can be characterised as defensive absorption, mirroring a very sceptical position to the application of internal market principles on healthcare. As observed in figure 1, Danish courts have only made reference to the CJEU jurisprudence in one case, which was ruled by the Danish Supreme Court but did not grant the plaintiff the right to reimbursement of the costs of cross border care. 5 We have thus been unable to confirm the key role for national courts that Obermaier found for France, Germany and the UK (Obermaier 2009 ). Instead, the patient venue for claiming EU rights seems to be the quasi-judicial body of the National Agency for Patients' Rights and Complaints (Patientombuddet), which was formed in January 2011. The agency is the highest administrative authority that considers patient complaints and evaluates regions' decisions on applications for cross border care, among other issues concerning patients' rights. We compiled all of the decisions from the National Agency for Patients' Rights from January 2011 to January 2015. 6 In that period, 16 cases considered EU law and the right to have healthcare treatment in another EU member state. In 9 cases, the agency supported the region's refusal to reimburse the costs of cross border care. In 7 cases, the agency went against the region's decision and the right to cross border healthcare was granted. With a time lag of more than 8 years, Danish application in law and practice stands out as mirroring strong preferences for status quo, according to which the rights to cross-border health care remain limited. The position appears as self-reliant, defensive and for a considerable time period rather immune to internal and external criticism. In regard to the judicialisation through national courts, Danish courts practically took no role at all. Quasi-judicial proceedings instead pushed for a certain extension of de facto rights; however, in a numerical sense, it was a right extended to very few.
Transposing the patients' rights directive in Denmark
In Denmark, the Ministry of Health was responsible for the transposition of the Directive, whereas the regions and healthcare providers were responsible for the practical implementation of the Directive. The Danish law entered into force 1 January 2014, which meant that Denmark did not meet the transposition deadline of 25th October 2013.
Concerning the outcome of the PRD, the implementation of article 8 is central. The Danish transposition of this article does not, however, facilitate patients' outflow but instead maintains the prior authorisation policy. For both hospital care and highly specialised and high-cost care that does not require hospitalisation, authorisation must be issued (Danish law proposal, L 33 as adopted 20. December 2013; § 89). The law obliges the Danish Health and Medicines Authority to issue a list setting out which treatments require prior authorisation. The issued list sets out that all treatments that require at least one night of hospitalisation plus all treatments listed in the 'plan for specialization', 'specialeplanen', as a 'regional' or 'highly specialized' function require authorisation. The list simply links to the 'plan for specialization', where a somewhat overwhelming range of treatments appears. According to the directive's article 8.5, the national authority is obliged to grant authorisation if the patient is entitled to the healthcare in question but it cannot be provided 'within a time limit which is medically justifiable'. What constitutes a 'medically justifiable time limit' is decided on a case-by-case basis by the responsible civil servant upon consulting the relevant medical expertise. The room for discretion available here makes it likely that the decision will favour national healthcare supplies.
In sum, Denmark has been slow to adapt to the sequences of EU-induced change. National courts did not act as catalysts for domestic change but were instead reluctant to act as decentral enforcers of CJEU jurisprudence. Quasi-judicial agencies were somewhat more active, but their decisions did not result in major political or administrative change. The transposition of the directive implies yet other gradual steps of change to allow for EU cross-border healthcare but does so without bringing Denmark outside its comfort zone of a nationally controlled healthcare system.
Judicialisation in the Case of Spain
The basic Spanish health care model belongs to the NHS. The citizens' right to healthcare was inserted in the Spanish constitution of 1978, and universalism was later articulated in the general health bill of 1986 (LopezCasasnovas et al. 2005: 221-222) .
At the same time that Spain developed into a tax financed model with universal coverage, welfare governance has devolved. During a lengthy process from approximately 1979-2002, the autonomous communities consolidated these competences to provide healthcare (Greer 2009, 143) . The process of devolution of health competences carried with it legislative attempts to balance the tension between regional autonomy and equal rights for the Spaniards, regardless of their region of residence (García-Armesto et al., 2010: 233) . Against this background, a new national benefit basket was introduced by the national cohesion and quality act, enforced by 2006. The national benefit basket defines the basic rights, and regions may add to these. Considerable regional differences exist in the access to and the quality, safety and efficiency of the healthcare sector (García-Armesto et al., 2010) . Furthermore, the regional autonomy implies that patients cannot choose healthcare in another region. Thus, free choice is not a part of patient rights in Spain.
As in Denmark, the general practitioner is -across regions -the important gatekeeper of the system. The GP is always the first point of contact, except for emergencies. The patient will visit the family doctor with whom the patient is registered, and the doctor will then refer for specialised or hospital care (García-Armesto et al., 2010: 191-192) .
Judicial Europeanisation of healthcare in Spain: Unobserved courts
Compared with the Danish case, Spanish courts have been more active in considering EU law in national jurisprudence. Furthermore, Spanish practices have been considered before the CJEU in two cases. 13 In the first case, a Social Court from Madrid 14 sent a preliminary reference to the CJEU about the obligation to reimburse the costs of healthcare in a non-member country (Switzerland) due to the diagnosis and recommendations made by a GP established in Germany. The CJEU laid down that the Spanish competent institution is bound by the diagnosis and choice of treatment of the doctors that were authorised in another member state. In the second case, the Commission issued an infringement procedure against Spain. 15 The Court, however, supported the Spanish government's position, laying down that in the event of non-planned treatment, Spain, as the competent member state, did not have to reimburse the total cost of the health service provided in another member state if the coverage of the service provided was, according to the national legislation, inferior to the one that would have been provided in Spain.
With regard to national court cases, Spanish courts have based their decisions on CJEU jurisprudence in 35 cases and have thus been more active enforcers of EU law than Danish courts. In 19 of these cases, national courts granted cross border healthcare to the Spanish patients. A closer look into the decisions shows how in 15 occasions, the courts implemented CJEU jurisprudence to allow access to specialised treatment in another Member State or in countries with agreements with the EU (e.g., Switzerland). In the rest of the cases, EU law was not part of the main rationale of the ruling but was cited in support of granting access to 1) the Spanish private system and 2) to non-EU member states, such as Panamá. This resistance to judicial Europeanisation is based on deference from the administration to the parliament and the legislative process (Greer and Martín de Almagro Iniesta 2014, 377-378) . This deference is also present during national litigation processes, where the institutional position of the State lawyer appears to pay considerable attention to the governmental position. A State lawyer is likely to hesitate to allege the incompatibility of national law with EU law, even if there are legal grounds for such actions, because this can affect future career opportunities (Mayoral, 2014: 130-131) . Furthermore, the regional governments neglected the rulings:
"regional health ministries, who are the core of the health system, are more interested in running health services than in tracking, understanding, or implementing ECJ rulings" (Greer and Martín de Almagro Iniesta 2014, 377) .
This neglect was possible because regional authorities rely primarily on the health ministry in Madrid for an impact analysis of the Court's rulings and do not take any action by themselves. Nevertheless, despite its competence in EU health policies, the Health Ministry in Madrid did not adopt any measure or elaborated policies for regional authorities to follow in relation to the implementation of the CJEU health care
jurisprudence (Interviews, 6. September 2013 and 9. September 2013) .
Transposing the patient rights directive in Spain
Through the Council negotiations of the patient rights directive, Spain was one of the major voices against the proposal of the Commission (interviews, December 2009; July 2010). Spain led the blocking majority that in December 2009 vetoed against the compromise text of the Swedish presidency, but when it took over the chair of the presidency in January 2010, it managed to establish a compromise between the member states, which allowed for the final adoption of the directive (Martinsen 2015) .
The transposition of the directive has been marked by different tensions. First, the division of labour that the directive implies collides with the devolved healthcare governance of Spain. As a directive, the Health Ministry in Madrid is in charge, which normally has very little competence in the policy area. Representatives from the autonomous regions argue that it has been difficult for them to influence both the negotiations of the directive and its transposition. In light of the lengthy process of devolution, the leeway that the directive gives to the national ministry is regarded as problematic from a regional point of view (Interviews, November 2012; September 2013) . The Ministry of Health has transposed the directive, whereas the regional governments have had the possibility to give input in the Inter-territorial Council that settles issues between regions and the central government.
As emphasised above, the high degree of regional autonomy implies that key dimensions of the provision of healthcare differ across Spain. The transposition of the patient rights directive amplifies such differences, thus de facto reinforcing inequalities. First, the regions operate with different prices for healthcare (interview, September 2013). Regional tariffs comprise the level at which the patient will be reimbursed if he/she is treated in another member state. A Spanish patient from Andalusia will thus be reimbursed according to a different tariff than a resident in Extremadura. Second, benefit packages differ across regions.
A patient from a region with a broader coverage will thus in principle be able to access a broader cross border supply. Third, because some regions operate with their own waiting time guarantees, the definition of 'undue delay' must also differ across regions.
Transposition in Spain has been marked by other important misfits between the national model and the directive. Spanish patients are tied to their regions and cannot access healthcare in other regions. Recently, 'choice' has been introduced across national borders. Furthermore, public healthcare does not allow Spanish patients to be treated by non-contracted providers. The NHS system in Spain owns the providers, which the system considers to be a means of quality and safety assurance (interview, December 2009 To summarise, similar to Denmark, Spain has been reluctant to adapt to the sequences of EU-induced change.
Although national courts managed to extend cross-border healthcare rights of Spanish patients in 15 cases by means of the CJEU jurisprudence, these court cases did not change the administrative practices or national law. CJEU case-law was not devoted political or administrative attention, and national courts did not have the power or the sword to instigate broader national change (Conant 2002) .
Conclusion
This paper has examined the impact of judicialisation on the right to cross border healthcare in Denmark and Spain. We expected ex-post national judicial, administrative and political responses and, in particular, courts' activation of EU law to be important for the de facto change that EU legal integration may cause. We found different judicial responses in the two member states. In Denmark, national courts did not activate EU law.
It is remarkable that only one court case considered EU law for its decision but that it ultimately did not grant the right to cross border care. Quasi-judicial proceedings proved to be the more accessible venue for patients to demand their EU rights. Sixteen cases considered the right to cross border healthcare between 2011-2015; in 7 of these cases, the right to the reimbursement of cross-border healthcare costs were granted, thereby de facto extending rights. However, in general, courts have been weak players in the push for judicialised rights in Denmark, and the 'quasi-judicialisation' identified has not been able to push for notable administrative or political change. In Spain, national courts did take CJEU jurisprudence into national courtrooms, and in 15 of these 35 cases, Spanish patients became entitled to EU cross border healthcare paid by the public purse. Although Spain had more court cases than Denmark, only 15 cases produced de facto rights, which demonstrates that court rulings -even in a constitutional democracy such as Spain -are hardly sufficient as leverage for general rights. Neither CJEU rulings nor the national court cases were able to instigate more general political or administrative change in Spain. Political and administrative actors largely ignored the case-law of the European court, and the infringement procedure that the Commission pushed forward did not correct the legislative or administrative practices in Spain. In addition, national court cases remained unobserved by the political and administrative elite, thus quelling a broader judicial impact by means of bureaucratic and political disregard.
Administrative and political responses were found to be quite similar in Denmark and Spain. The two universalistic NHS models have long resisted EU impact on their healthcare systems, finding that their models are fundamentally unfit for patient-driven free choice across borders. Such protectionist positions are motivated by the overall healthcare legacies embedded in the national models but also reasoned in budgetary and governance justification. An EU free choice model constitutes a financial threat to fragile publicly financed models with equality as the basic legitimising norm, and the centralisation implied in EU governance disturb models with a high degree of decentralisation. The directive has been transposed in lawful texts in both member states, but the ability for patients to make actual use of their newly gained rights is low. The ex-post responses to in the two member states is summarised in table 3 below: In 2014 thirty-five patients have been reimbursed for cross border healthcare from the Danish authorities, but only 11 in Spain. We consider this a low outcome of judicialisation and its subsequent EU law -litigated, designed and negotiated in great detail and for long time to facilitate access to crossborder healthcare in the EU. However, de facto rights are so far for the very few.
However, the rather minimal change found in both member states may change over time. 
